Tower Research Capital LLC (Trc) Atea Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$4.87 Billion
Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,617 shares of AVIR stock, worth $10,814. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,617

Previous 11,734 69.18%

Holding current value

$10,814

Previous $39,000 69.23%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$2.93 - $3.82 $23,782 - $31,006	-8,117 Reduced 69.18%	3,617 $12,000
Q3 2024 Nov 14, 2024	BUY	$3.17 - $4.02 $7,138 - $9,053	2,252 Added 23.75%	11,734 $39,000
Q2 2024 Aug 13, 2024	BUY	$3.31 - $4.04 $26,519 - $32,368	8,012 Added 545.03%	9,482 $31,000
Q1 2024 May 15, 2024	SELL	$3.09 - $4.56 $89,208 - $131,647	-28,870 Reduced 95.15%	1,470 $5,000
Q4 2023 Feb 13, 2024	BUY	$2.8 - $3.35 $47,717 - $57,090	17,042 Added 128.15%	30,340 $92,000
Q3 2023 Nov 14, 2023	BUY	$3.0 - $3.79 $22,656 - $28,622	7,552 Added 131.43%	13,298 $39,000
Q2 2023 Aug 14, 2023	BUY	$3.21 - $5.06 $8,313 - $13,105	2,590 Added 82.07%	5,746 $21,000
Q1 2023 May 09, 2023	SELL	$3.0 - $4.97 $53,664 - $88,903	-17,888 Reduced 85.0%	3,156 $11,000
Q4 2022 Feb 10, 2023	BUY	$4.35 - $6.17 $14,089 - $19,984	3,239 Added 18.19%	21,044 $101,000
Q3 2022 Nov 10, 2022	SELL	$5.49 - $8.79 $31,276 - $50,076	-5,697 Reduced 24.24%	17,805 $102,000
Q2 2022 Aug 15, 2022	BUY	$5.33 - $8.18 $118,341 - $181,620	22,203 Added 1709.24%	23,502 $167,000
Q1 2022 May 12, 2022	BUY	$5.5 - $9.19 $253 - $422	46 Added 3.67%	1,299 $9,000
Q4 2021 Feb 14, 2022	SELL	$7.67 - $44.59 $40,927 - $237,932	-5,336 Reduced 80.98%	1,253 $11,000
Q3 2021 Nov 15, 2021	BUY	$21.33 - $35.06 $104,687 - $172,074	4,908 Added 291.97%	6,589 $231,000
Q2 2021 Aug 16, 2021	BUY	$19.22 - $59.08 $18,297 - $56,244	952 Added 130.59%	1,681 $36,000
Q1 2021 May 17, 2021	BUY	$41.42 - $88.44 $16,443 - $35,110	397 Added 119.58%	729 $45,000
Q4 2020 Feb 16, 2021	BUY	$26.36 - $41.78 $8,751 - $13,870	332 New	332 $14,000

Others Institutions Holding AVIR

# of Institutions

112

Shares Held

50.9M

Call Options Held

7.6K

Put Options Held

38.7K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $249M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Atea Pharmaceuticals, Inc. Transaction History